Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Glucose-dependent insulinotropic polypeptide (GIP) and glucagonlike peptide-1 are gut-derived incretin hormones, it can augment glucose-stimulated insulin secretion and also to promote satiety. GIPR has been identified in genome-wide association studies (GWAS) of body mass index (BMI) measurements. It can develop a therapeutic GIPR antagonist for the treatment of obesity.